Company intelligence / Profile preview

Shanghai Longyu Biotechnology

Shanghai, Shanghai, China

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Shanghai Longyu Biotechnology is a commercial supplier and manufacturer with a broad portfolio of pharmaceutical intermediates, peptides, hormones/steroids, SARMs, and plant extracts sold worldwide to the pharmaceutical, fine chemical, and research markets. They do not publicly report distinct clinical trial results, as they are not a drug development biotech company.

Therapeutic areas: Men's HealthEndocrinologyMetabolic DisordersOther
Modalities: Small moleculePeptidesSteroidsBiologic
Industry: Chemicals & Materials

Partnerships

Not publicly statedStructurally partners with worldwide distributors and pharmaceutical manufacturers

Beyond the preview

Go deeper on Shanghai Longyu Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Longyu Biotechnology.

Explore the full profile